SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-053541
Filing Date
2014-08-19
Accepted
2014-08-19 18:54:05
Documents
1
Period of Report
2014-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3265
  Complete submission text file 0001209191-14-053541.txt   4636
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 101 WESTCOTT SUITE 603 HOUSTON TX 77007
Business Address
CHANG NANCY T (Reporting) CIK: 0001135041 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19825 | Film No.: 141053501